China Multiomics Market Size & Outlook, 2023-2030
China multiomics market, 2018-2030 (US$M)
Related Markets
China multiomics market highlights
- The China multiomics market generated a revenue of USD 105.7 million in 2023 and is expected to reach USD 309.5 million by 2030.
- The China market is expected to grow at a CAGR of 16.6% from 2024 to 2030.
- In terms of segment, product was the largest revenue generating product & service in 2023.
- Services is the most lucrative product & service segment registering the fastest growth during the forecast period.
Multiomics market data book summary
| Market revenue in 2023 | USD 105.7 million |
| Market revenue in 2030 | USD 309.5 million |
| Growth rate | 16.6% (CAGR from 2023 to 2030) |
| Largest segment | Product |
| Fastest growing segment | Services |
| Historical data | 2018 - 2022 |
| Base year | 2023 |
| Forecast period | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Services, Product |
| Key market players worldwide | Thermo Fisher Scientific Inc, Illumina Inc, Danaher Corp, Shimadzu Corp, Bruker Corp, Qiagen NV, Agilent Technologies Inc, BD, Revvity Inc, BGI Group |
Other key industry trends
- In terms of revenue, China accounted for 4.5% of the global multiomics market in 2023.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In Asia Pacific, China multiomics market is projected to lead the regional market in terms of revenue in 2030.
- India is the fastest growing regional market in Asia Pacific and is projected to reach USD 194.0 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Multiomics Market Scope
Multiomics Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
China multiomics market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to multiomics market will help companies and investors design strategic landscapes.
Product was the largest segment with a revenue share of 57.14% in 2023. Horizon Databook has segmented the China multiomics market based on services, product covering the revenue growth of each sub-segment from 2018 to 2030.
The growth of the biotechnology and pharmaceutical sectors significantly contributes to the expansion of the genomics market. Furthermore, as these industries advance, the biotechnology industry in China is expected to grow, resulting in an increased market share for genomics in the country.
The improving healthcare infrastructure and the rising healthcare expenditure by both pharmaceutical companies & the government are anticipated to propel the growth of multiomics market.
For instance, the National Genomics Data Center (NGDC) in China has been actively providing a suite of newly developed and regularly updated database resources to assist in managing the rapidly expanding pool of multiomics data.
Reasons to subscribe to China multiomics market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of China multiomics market databook
-
Our clientele includes a mix of multiomics market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the China multiomics market , including forecasts for subscribers. This country databook contains high-level insights into China multiomics market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
China multiomics market size, by product & service, 2018-2030 (US$M)
China Multiomics Market Outlook Share, 2023 & 2030 (US$M)
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
